BlackRock Institutional Trust Company, N.A. - PERNIX THERAPEUTICS HLDGS IN ownership

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$1,002,000
+215.1%
1,610,542
+126.7%
0.00%
Q2 2016$318,000
-80.0%
710,276
-53.2%
0.00%
Q1 2016$1,592,000
-58.2%
1,516,585
+17.5%
0.00%
-100.0%
Q4 2015$3,807,000
+6.5%
1,290,434
+14.1%
0.00%0.0%
Q3 2015$3,574,000
-45.2%
1,131,074
+2.7%
0.00%0.0%
Q2 2015$6,522,000
-41.5%
1,101,650
+5.7%
0.00%
-50.0%
Q1 2015$11,141,000
+22.0%
1,042,145
+7.1%
0.00%
+100.0%
Q4 2014$9,133,000
+25.8%
972,614
+2.9%
0.00%0.0%
Q3 2014$7,260,000
-1.1%
945,252
+15.6%
0.00%0.0%
Q2 2014$7,342,000
+146.2%
817,561
+46.7%
0.00%0.0%
Q1 2014$2,982,000
+149.1%
557,391
+17.4%
0.00%
Q4 2013$1,197,000
+12.7%
474,933
+21.6%
0.00%
Q3 2013$1,062,000
-21.0%
390,541
+4.9%
0.00%
Q2 2013$1,344,000372,2240.00%
Other shareholders

There were no reported owners of PERNIX THERAPEUTICS HLDGS IN in Q4 2016.

NameSharesValueWeighting ↓
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders